Xiang Zhou
周翔
Xiang Zhou is a Chinese venture capital figure who previously led Alpha, the early-stage arm of China Renaissance, before departing to found Mind Capital (明德资本), a financial advisory firm whose clients included synthetic-biology company Bluepha Microbiology . He later joined Linear Capital, where he has held operations roles including office manager and administrative manager . The bundle contains no further biographical detail or coverage of his investment track record.
AI-generated — may contain errors, please verify.
Coverage
Linear Capital｜Linear Path, Nonlinear Growth
We strive to be the best Data Intelligence Technology Fund in China.
Linear Capital｜Linear Path, Nonlinear Growth
We strive to be the best Data Intelligence Technology Fund in China.
180 Days Since Fan Bao Went Missing: One Man and the Fate of an Industry
China Renaissance's growth story is also a history of how China's new economy collided with the world.
Fan Bao's disappearance is a situation no one wanted to see.
"The Long March has only just begun."
AI-powered pharmaceutical formulation development company "METiS" announced the completion of a multi-million dollar angel round — Source Code Capital participated as a follow-on investor.
The world's first startup to use AI to drive pharmaceutical formulation development, dedicated to providing drug companies with rapid, precise intelligent formulation R&D through high-throughput formulation platforms and AI computing technologies.
